| Model ID | 13-065-01 |
| Model Name | Wang 2013 |
| Pubmed ID | 23485798 |
| First Author | Wang |
| Journal | Cardiology |
| Year | 2013 |
| Title | Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction |
| Primary Index Condition | Coronary Artery Disease (CAD) |
| Secondary Index Condition | Acute Coronary Syndrome (ACS) |
| Outcome | No Reflow |
| Model Sample Size | 1615 |
| Cohort Sample Size | 1615 |
| Number of Events | 343 |
| Follow-Up Duration | Short (<3 months) |
| AUROC | 0.757 |
| Calibration Reported | 1 |
| Covariates | Age >=55 years; Age <55 years; Plasma glucose on admission >=12.0 mmol/l; Plasma glucose on admission <12.0 mmol/l; Neutrophil count >=8.81 x 10^9/l; Neutrophil count <8.81 x 10^9/l; Killip class 4; Killip class <4; Administration of beta blocker: yes; Administration of beta blocker: no; Time to hospital admission: >=4 h; Time to hospital admission: <4 h |
| Mesh Terms | To be updated |
| Number of Validations | 1 |
